MRD / Regn No. : THBC\23-24\01470 Date : 13/07/2026
Patient Name : Laxman Ramkrishnan Age & Gender : 74 Yrs. / Male
Contact No. : 9821711292 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (13/Jul/2005) |
Subjective : T2DM-17YRS,HBA1C AROUND 8.5%,STABLE / NO HYPOS,RETINA STABLE,MACROALB 1126 - STABLE AT 170-200,THOUGH POST MEAL BY LAB IS 84 - HOME MONITORING IS 130-140 - IF TRIES TO REUDCE DOSE - SUGAR GOES UP,WILL ADJUST DOSES IF NEEDED
Objective : 12-SEP-2026 REPORTS,CR-1.32,PSA-6.44,U ACR-69.28,HBA1C-7.4%,FBS-105/ PPBS-79
Plan : ADDING LYVELSA 10 MG - WILL RECHECK SERUM POTASSIUM / SERUM CREATNINE IN 2 WEEKS - IF POTASSIUM INCREASES - CAN STOP,USG KUB / PROSTATE / PVR - RISING PSA LEVELS  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TRIVOLIB FORTE 2 ORAL 1-0-0 BBF
4 MTHS
2 DEGLUDEC (INJ U100)
TRESIBA
SQ 0-0-18 BEDTIME
4 MTHS
3 NOVORAPID SQ 8-8-8 BEFORE MEALS
4 MTHS
4 TABLET DAPAGLIFLOZIN (10MG)
GLUXIT 10 MG
ORAL 1-0-0 BBF
4 MTHS
5 ROSEDAY A 10 MG ORAL 0-0-1 AD
4 MTHS
6 TELMISARATAN 80 MG
TAZLOC 80 MG
ORAL 1-0-0 ABF
4 MTHS
7 LYVELSA 10 MG ORAL 1-0-0 ABF
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 24/Jun/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C / URINE FOR MICROALB:CREAT RATIO > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: